Author: Emily Boland
-

Control Bionics (ASX:CBL) Looks to Solidify Global Presence
Rob Wong, CEO of Control Bionics, chats with Alan Kohler from Eureka Report to discuss the latest news from the newly ASX-listed business. ” … the fundamental point about that was that your brain sends very, very fast signals to muscles to act because that’s the fight or flight mechanism. Most of the outcomes that…
-

Control Bionics (ASX:CBL) Partners with Numotion as Northeastern US Reseller of Assistive Technology Solutions
Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering with Numotion, a leading provider of Complex Rehab Technology (CRT) to offer the Control Bionics’ Trilogy product line.
-

Control Bionics set to enter the ASX bourse next week; inspired by Stephen Hawking and already FDA approved
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric systems. Examples of such conditions include motor-neuron disease, cerebral palsy, and spinal cord injuries. Control Bionics’ flagship product, NeuroNode 3, is watch-sized…
-

Control Bionics Launches Latest Product Extension
Control Bionics announces the newest addition to its Augmentative and Alternative Communication (AAC) device line, the GridPad Trilogy™ communication solution. The new neuro-based voice output communication aid is intended to help people living with paralysis and loss of speech find their voice.
-

Opening Back Up In-Person Assessments
As we’ve globally transitioned into telepresence communication, we will still be offering our remote assessments alongside our industry-leading customer support. We understand that some communication needs, and assessments, may be challenging to support remotely and we are pleased to be opening back up in-person meetings and assessments.
-

Cleaning + Disinfecting Your Control Bionics Communication Device
Your NeuroNode Trilogy should be cleaned and disinfected on a regular basis. We recommend Super Sani-Cloth Germicidal Disposable Wipes for this. While Control Bionics routinely follows these procedures internally, we understand in light of the Covid-19 virus that these best practices may also be extended to our clients as well as their caregivers and facilities. Please…
-

The Most Wide-ranging AAC Solution Gets a Big Boost in Wearability and Durability
Control Bionics was founded by Peter Shann Ford in 2006 to address the most difficult cases of loss of speech and mobility. Ford and the Control Bionics team have added much to the original work, particularly in the miniaturization of the equipment, in the improvement to signal processing, in ease of use, and in the…
-

New Assistive Communication Tech Promises Faster Speed and Less Fatigue for ALS
The NeuroNode Trilogy provides three access methods in a single funding accessible solution for degenerative conditions. MILFORD, OH – Feb.5, 2019 – Control Bionics Launches a new AAC package, the NeuroNode Trilogy, that significantly reduces user fatigue and increases speed for severely disabled people with conditions like ALS/MND, SCI, SMA, and Cerebral Palsy. Building on their successful…
-

Medicare Approves Life-Changing Technology for People with Disabilities
The NeuroNode provides a new solution for those with ALS/MND, Cerebral Palsy and more. Milford, Ohio, October 26, 2018 — Control Bionics’ NeuroNode, a revolutionary life-altering assistive technology product, is universally available for people with disabilities. Control Bionics released the NeuroNode in January of 2017 at the ATIA (Assistive Technology Industry Association) in Orlando, Florida. The…



